Laurence Borge

1.9k total citations
12 papers, 1.1k citations indexed

About

Laurence Borge is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Laurence Borge has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Rheumatology. Recurrent topics in Laurence Borge's work include Cancer, Hypoxia, and Metabolism (3 papers), Blood properties and coagulation (2 papers) and Skin and Cellular Biology Research (2 papers). Laurence Borge is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Blood properties and coagulation (2 papers) and Skin and Cellular Biology Research (2 papers). Laurence Borge collaborates with scholars based in France, Norway and Australia. Laurence Borge's co-authors include Juan Iovanna, M Adolphe, Sébastien Letard, Sylvie Demignot, Patrice Dubreuil, Sophie Lac, Tristan Gicquel, Edwige Voisset, Olivier Hermine and Phillip S. Leventhal and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Laurence Borge

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Borge France 12 423 311 263 221 191 12 1.1k
Vinay Sagar United States 19 712 1.7× 361 1.2× 231 0.9× 142 0.6× 214 1.1× 46 1.3k
Philippe Pujuguet Belgium 16 542 1.3× 446 1.4× 153 0.6× 112 0.5× 140 0.7× 22 1.1k
Yongfeng Xu China 21 572 1.4× 488 1.6× 293 1.1× 430 1.9× 172 0.9× 72 1.7k
Kenneth R. Shroyer United States 22 860 2.0× 350 1.1× 229 0.9× 121 0.5× 210 1.1× 33 1.5k
Hee Jin Cho South Korea 21 513 1.2× 421 1.4× 322 1.2× 256 1.2× 234 1.2× 67 1.5k
Kyoko Arai Japan 18 595 1.4× 250 0.8× 112 0.4× 189 0.9× 188 1.0× 53 1.0k
Nicole Parker Australia 10 388 0.9× 391 1.3× 276 1.0× 165 0.7× 179 0.9× 16 1.1k
Colin Cooper United Kingdom 17 639 1.5× 208 0.7× 299 1.1× 58 0.3× 332 1.7× 28 1.1k
Rebecca Sowers United States 19 801 1.9× 562 1.8× 270 1.0× 171 0.8× 460 2.4× 24 1.5k
Shuaishuai Xu China 17 294 0.7× 460 1.5× 189 0.7× 170 0.8× 168 0.9× 34 1.1k

Countries citing papers authored by Laurence Borge

Since Specialization
Citations

This map shows the geographic impact of Laurence Borge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Borge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Borge more than expected).

Fields of papers citing papers by Laurence Borge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Borge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Borge. The network helps show where Laurence Borge may publish in the future.

Co-authorship network of co-authors of Laurence Borge

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Borge. A scholar is included among the top collaborators of Laurence Borge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Borge. Laurence Borge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Liu, Juan, Chao Chen, Tuo Wei, et al.. (2021). Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer. SHILAP Revista de lepidopterología. 1(1). 21–34. 87 indexed citations
2.
Masoud, Rawand, Gabriela Reyes‐Castellanos, Sophie Lac, et al.. (2020). Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer. Cell Reports Medicine. 1(8). 100143–100143. 114 indexed citations
3.
Grand, Marion Le, Raphaël Bergès, Eddy Pasquier, et al.. (2017). Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression. Scientific Reports. 7(1). 45136–45136. 21 indexed citations
4.
Olivares, O. Porta, Jared R. Mayers, Victoire Gouirand, et al.. (2017). Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nature Communications. 8(1). 16031–16031. 309 indexed citations
5.
6.
Dubreuil, Patrice, Sébastien Letard, Marco A. Ciufolini, et al.. (2009). Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT. PLoS ONE. 4(9). e7258–e7258. 334 indexed citations
7.
Borge, Laurence, et al.. (2000). [Rehabilitation of women with breast cancer].. PubMed. 120(23). 2749–54. 11 indexed citations
8.
Borge, Laurence, François Lemare, Sylvie Demignot, & M Adolphe. (1997). Restoration of the differentiated functions of serially passaged chondrocytes using staurosporine. In Vitro Cellular & Developmental Biology - Animal. 33(9). 703–709. 24 indexed citations
9.
Borge, Laurence, Sylvie Demignot, & M Adolphe. (1996). Type II transglutaminase expression in rabbit articular chondrocytes in culture: relation with cell differentiation, cell growth, cell adhesion and cell apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1312(2). 117–124. 30 indexed citations
10.
Demignot, Sylvie, Laurence Borge, & M Adolphe. (1995). Transglutaminase activity in rabbit articular chondrocytes in culture. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1266(2). 163–170. 21 indexed citations
11.
12.
Fosså, Sophie D., et al.. (1987). The treatment of advanced metastatic seminoma: experience in 55 cases.. Journal of Clinical Oncology. 5(7). 1071–1077. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinay Sagar Breakdown of academic impact, for papers by Philippe Pujuguet Breakdown of academic impact, for papers by Yongfeng Xu Breakdown of academic impact, for papers by Kenneth R. Shroyer Breakdown of academic impact, for papers by Hee Jin Cho Breakdown of academic impact, for papers by Kyoko Arai Breakdown of academic impact, for papers by Nicole Parker Breakdown of academic impact, for papers by Colin Cooper Breakdown of academic impact, for papers by Rebecca Sowers Breakdown of academic impact, for papers by Shuaishuai Xu
Rankless by CCL
2026